EUVIMEDEUVIMED entdecken
Crossref

12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients

Konstantinos Tigkiropoulos iD, Katerina Sidiropoulou, Manolis Abatzis-Papadopoulos, Ioannis Lazaridis, Nikolaos Saratzis

Angiology · 2025

DOI: 10.1177/00033197231213679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, 2025. Verfasst von Konstantinos Tigkiropoulos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Papageorgiou General Hospital, Aristotle University, Thessaloniki,…. Hauptthemen laut MEDLINE: Stents, Carotid Stenosis, Endovascular Procedures, Embolic Protection Devices. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual layer mesh stents constitute a novel treatment option for patients who undergo carotid artery stenting (CAS). The aim of this prospective study is to report 12 month outcomes of patients who underwent CAS with CGuard (Inspire MD, Tel Aviv, Israel) microNET self-expanding stent with embolic protection system in a tertiary center from October 2018 to March 2022. Primary endpoints included in-stent restenosis >70% verified by ultrasound (DUS), ipsilateral transient ischemic attack (TIA), and stroke at 12 months. Secondary endpoints included cardiovascular-related mortality (stroke, myocardial infarction, heart failure) and all-cause mortality during follow-up. One hundred thirteen patients were included in the study (male 72.5%), symptomatic 47.8%. Median follow-up was 25 months (2–48). By 12 months, there was one in-stent occlusion that manifested as stroke (1/113, 0.8%) but no other forms of in-stent restenosis. Two patients experienced contralateral TIA (1.7%). CVRM was 3.5% (4 MI) and all-cause mortality was 6% at follow-up. This prospective study shows that CAS with CGuard MicroNET-covered stent is safe with minimal neurological adverse events at 12 months follow-up. Larger, and longer-term studies are necessary to define CGuard long-term safety and protection against carotid-related stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StentsCarotid StenosisEndovascular ProceduresEmbolic Protection DevicesHumansMaleFemaleAgedProspective StudiesMiddle AgedTreatment OutcomeTime FactorsProsthesis DesignAged, 80 and overIschemic Attack, Transient

Stichwörter der Autor:innen

CGuardcarotid artery stenosiscarotid artery stentingdual layer mesh stents

Autor:innen und Institutionen

  • Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Papageorgiou General Hospital, Aristotle University, Thessaloniki, Greece.

ORCID-Profile: Konstantinos Tigkiropoulos

Zitieren

APA

Tigkiropoulos, K., Sidiropoulou, K., Abatzis-Papadopoulos, M., Lazaridis, I., & Saratzis, N. (2025). 12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients. Angiology. https://doi.org/10.1177/00033197231213679

Vancouver

Tigkiropoulos K, Sidiropoulou K, Abatzis-Papadopoulos M, Lazaridis I, Saratzis N. 12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients. Angiology. 2025. doi:10.1177/00033197231213679

BibTeX
@article{Tigkiropoulos2025,
  author = {Tigkiropoulos, Konstantinos and Sidiropoulou, Katerina and Abatzis-Papadopoulos, Manolis and Lazaridis, Ioannis and Saratzis, Nikolaos},
  title = {12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients},
  journal = {Angiology},
  year = {2025},
  doi = {10.1177/00033197231213679}
}
Kostenlos starten →